In a 29-year-old woman with cocaine and alcohol intoxication who received 2 mg IV lorazepam (Ativan) and a 1‑L fluid bolus, her heart rate remains 144 bpm; what is the next management step?

Continue Benzodiazepines and Reassess for Specific Complications

Administer additional benzodiazepines (e.g., lorazepam 2 mg IV) to further control sympathomimetic effects, as benzodiazepines remain the mainstay of initial management for cocaine-induced tachycardia and agitation 1. The heart rate of 144 bpm after initial treatment indicates persistent sympathetic overdrive that requires more aggressive sedation.

Immediate Next Steps

1. Escalate Benzodiazepine Dosing

• Give lorazepam 2 mg IV (can repeat every 10-15 minutes as needed) 2
• The 2023 AHA guidelines explicitly state that benzodiazepines remain the mainstay of initial management for blood pressure and psychomotor agitation in acute cocaine poisoning 1
• Your initial 2 mg dose was appropriate but insufficient—cocaine toxicity often requires cumulative doses much higher than typical anxiolysis
• Monitor for respiratory depression, though this is the acceptable trade-off for controlling dangerous sympathomimetic effects 2

2. Obtain a 12-Lead ECG Immediately

This is critical to determine your next pharmacologic intervention:

• If QRS > 100 ms (wide-complex tachycardia): Administer sodium bicarbonate 1-2 mEq/kg IV bolus (Class 2a recommendation) 1

  • Cocaine blocks cardiac sodium channels similar to Class Ic antiarrhythmics
  • Sodium bicarbonate reverses this through competitive binding and alkalemia
  • Can also consider lidocaine for wide-complex tachycardia (Class 2a) 1

• If narrow-complex sinus tachycardia with hypertension: Consider vasodilators if benzodiazepines fail

  • Options: nitroglycerin, phentolamine (α1-blocker), or calcium channel blockers (Class 2a) 1
  • These are reasonable for severe cocaine-induced hypertension and chest pain 1

3. Assess for Hyperthermia

• Check rectal or core temperature
• If temperature > 40°C (104°F): Initiate rapid external cooling immediately (Class 1 recommendation) 1
• Hyperthermia is rapidly life-threatening in cocaine toxicity and requires evaporative or immersive cooling 1

Critical Pitfalls to Avoid

DO NOT Use Pure β-Blockers

• Avoid metoprolol, propranolol, esmolol in cocaine toxicity
• Risk of unopposed α-adrenergic stimulation leading to paradoxical hypertension and coronary vasoconstriction 3, 4, 5, 6
• The 2010 AHA guidelines note that β-blocker safety is "controversial, with studies showing both benefit and harm" 3
• If β-blockade is absolutely necessary, use combined β/α-blockers (labetalol or carvedilol), which have shown safety in cocaine toxicity 5, 6

Alcohol Co-Ingestion Matters

• Cocaine + alcohol creates cocaethylene, which intensifies chronotropic effects 4
• This patient's alcohol use may explain the persistent tachycardia despite benzodiazepines
• Expect to need higher cumulative benzodiazepine doses than cocaine alone

Monitor for Acute Coronary Syndrome

• Cocaine causes coronary vasoconstriction, increased myocardial oxygen demand, and platelet activation 4
• Check troponin if chest pain develops or persists
• Young age does not exclude MI—cocaine users develop premature atherosclerosis 4

Ongoing Management Algorithm

1. Continue benzodiazepines until HR < 100 bpm and patient is calm (may require 10-20 mg total lorazepam)
2. Maintain IV hydration (already started appropriately)
3. If tachycardia persists despite adequate sedation:
   • Reassess ECG for wide-complex changes → sodium bicarbonate
   • Check for hyperthermia → cooling
   • Consider vasodilators if hypertensive (SBP > 180 mmHg)
4. Continuous cardiac monitoring for dysrhythmias (VT, VF risk from sodium channel blockade)
5. Serial troponins if any chest pain or ECG changes

Why This Approach

The 2023 AHA Focused Update on Cocaine Poisoning provides the most current evidence-based framework 1. The systematic review by Schwartz et al. (2016) supports benzodiazepines as first-line with only 8 treatment failures in 234 subjects, while noting that "benzodiazepines may not always effectively mitigate tachycardia" 5—explaining why your patient needs more aggressive dosing rather than a different agent.

The key is that persistent tachycardia at 144 bpm after 2 mg lorazepam represents inadequate sympathetic blockade, not treatment failure requiring a different drug class. Escalate the benzodiazepines while simultaneously evaluating for the specific life-threatening complications (wide-complex dysrhythmia, hyperthermia, severe hypertension) that require targeted antidotes.